up home page bottom

French German version Spanish version Italian version

header image

Monthly Archives: May 2009

Reproductive Rights as a Civil Right

Then came the great liberator, THE PILL! Women could have a career AND sex and not have to worry about an unplanned pregnancy. This was a big damn deal in the fight for equal pay. Companies used the ‘impeding-mommy’ excuse to deny women promotions. After all, women were only in the workforce ‘temporally’, until like good girls, we got pregnant and stayed home to fulfill our real job— wife and mother.That sounds insane more than 30-years later, but in the 60s and 70s the newspaper want ads were divided into two sections, MEN and WOMEN.

Share

Pharma, Social Media and Public Persuasion

Perhaps the most impressive site to date is Gardasil’s “Take a step against cervical cancer” profile on Facebook—with more than 100,000 fans. (For comparison, American Idol’s Facebook page has about 430,000 fans.) But the big difference between the two is that “Take a step” is a one-way communicator: no comments allowed.

Share

University of Alabama Developing New HPV-Vaccine

Richard B.S. Roden, a researcher at Johns Hopkins who was trained at the National Cancer Institute, has spent a decade develop­ing the new HPV-vaccine. He said it will protect against a wider range of HPV types than Gar­dasil and can be produced for perhaps less than $1 a dose.

Share

What Causes Cervical Cancer?

HPV is one causal factor in the development of cervical cancer. Medical researchers note other factors contribute to cervical cancer, such as: Poverty— limited or no access to medical services; tobacco use; eating habits; weakened immune system; hormonal medications; exposure to Diethylstilberstrol (DES); Douching; and Chemical exposure in work environment.

Share

How Independent Is The FDA

The Congress has repeatedly looked at how it wants to fund the FDA. So once, twice, and again, last year, the Congress decided that the best way to fund the FDA was to look to the pharmaceutical industry to provide a portion of the funds to help support review. That’s the decision of the Congress. The pharmaceutical industry has contributed the funds to support the review, because we think that has been an effective approach. We also think that it’s been a way of helping to advance science.

Share

FDA Recall of Class I SmartMonitor 2 Infant Apnea Monitor

Respironics and FDA notified healthcare professionals of a Class I recall of SmartMonitor 2 Infant Apnea Monitor, Models 4002 and 4003, used for the continuous monitoring of respiration and heart rate of infant patients in the home or in the hospital.

Share

Politics, Profits and Pharma

The following is a  transcript from the Public Television series, FRONTLINE. The program, Politics, Profits and Pharma was aired on  November 13, 2003.  I’ve kept in my files for years as a source reference document. This past week, while working on a paper with my writing partner, Leslie C. Botha, and I opened my FRONTLINE [...]

Share

Inside a Contract Research Organization (CRO)

The Health Decisions central system integrates all the components in a clinical study: data collection, adaptive randomization, site payments, administrative functions, and a reporting suite. “We’ve been using dedicated study websites for reporting and coordinating for 7-10 years,” says Rosenberg. “I assumed everyone was doing this. But almost nobody else does that. From a technology standpoint, this is a no brainer. It’s the quickest, easiest, most efficient way to distribute information.”

Share

The Atrophy Of Objectivity

Decades ago, clinical trials were conducted at academic settings that focused on the acquisition of knowledge and the completely objective discoveries of drugs and devices to benefit mankind. Then, in 1980, the Bayh-Dole Act, Public Law 96-517,was created, which allowed for such places with their researchers to profit off of their discoveries that were performed for pharmaceutical companies and others in the past.

Share

HPV-Vaccine, How We Got Here

markers before the trial. The study was selected for women who showed some sort of robust natural immunity that kept them from expressing the HPV markers. 859 were excluded from the final data analysis for technical reasons and the vast majority were found to be infected with HPV-16 before getting the vaccine.

Share